Annual Total Long Term Liabilities
$146.90 K
-$67.20 K-31.39%
December 31, 2023
Summary
- As of February 12, 2025, ENTO annual total long term liabilities is $146.90 thousand, with the most recent change of -$67.20 thousand (-31.39%) on December 31, 2023.
- During the last 3 years, ENTO annual total long term liabilities has risen by +$127.80 thousand (+669.11%).
- ENTO annual total long term liabilities is now -97.99% below its all-time high of $7.31 million, reached on December 1, 2021.
Performance
ENTO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$80.20 K
-$20.80 K-20.59%
September 1, 2024
Summary
- As of February 12, 2025, ENTO quarterly total long term liabilities is $80.20 thousand, with the most recent change of -$20.80 thousand (-20.59%) on September 1, 2024.
- Over the past year, ENTO quarterly long term liabilities has dropped by -$66.70 thousand (-45.41%).
- ENTO quarterly long term liabilities is now -98.90% below its all-time high of $7.31 million, reached on December 1, 2021.
Performance
ENTO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ENTO Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.4% | -45.4% |
| 3 y3 years | +669.1% | -59.2% |
| 5 y5 years | +100.0% | -80.7% |
ENTO Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.0% | at low | -98.9% | at low |
| 5 y | 5-year | -98.0% | -100.0% | -98.9% | -100.0% |
| alltime | all time | -98.0% | -100.0% | -98.9% | -100.0% |
Entero Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $80.20 K(-20.6%) |
| Jun 2024 | - | $101.00 K(-98.6%) |
| Mar 2024 | - | $7.10 M(+4731.0%) |
| Dec 2023 | $146.90 K(-31.4%) | $146.90 K(-11.5%) |
| Sep 2023 | - | $166.00 K(-10.1%) |
| Jun 2023 | - | $184.70 K(-6.0%) |
| Mar 2023 | - | $196.50 K(-8.2%) |
| Dec 2022 | $214.10 K(-97.1%) | - |
| Dec 2022 | - | $214.10 K(-7.4%) |
| Sep 2022 | - | $231.30 K(-72.2%) |
| Jun 2022 | - | $833.30 K(-78.4%) |
| Mar 2022 | - | $3.85 M(-47.3%) |
| Dec 2021 | $7.31 M(>+9900.0%) | $7.31 M(+2372.5%) |
| Sep 2021 | - | $295.70 K(+3.5%) |
| Jun 2021 | - | $285.80 K(+4230.3%) |
| Mar 2021 | - | $6600.00(-65.4%) |
| Dec 2020 | $19.10 K | $19.10 K(-39.4%) |
| Sep 2020 | - | $31.50 K(-27.8%) |
| Jun 2020 | - | $43.60 K(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2019 | - | $414.50 K(-6.4%) |
| Jun 2019 | - | $443.00 K(-8.9%) |
| Mar 2019 | - | $486.50 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $1.58 M(+5.3%) |
| Jun 2018 | - | $1.50 M(+12.8%) |
| Mar 2018 | - | $1.33 M(-0.7%) |
| Dec 2017 | $1.34 M(+11.7%) | $1.34 M(+2.3%) |
| Sep 2017 | - | $1.31 M(-16.0%) |
| Jun 2017 | - | $1.56 M(+20.0%) |
| Mar 2017 | - | $1.30 M(+8.3%) |
| Dec 2016 | $1.20 M(-20.0%) | $1.20 M(-50.0%) |
| Sep 2016 | - | $2.40 M(+60.0%) |
| Jun 2016 | - | $1.50 M(0.0%) |
| Mar 2016 | - | $1.50 M(0.0%) |
| Dec 2015 | $1.50 M(0.0%) | $1.50 M |
| Dec 2014 | $1.50 M | - |
FAQ
- What is Entero Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Entero Therapeutics?
- What is Entero Therapeutics annual total long term liabilities year-on-year change?
- What is Entero Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Entero Therapeutics?
- What is Entero Therapeutics quarterly long term liabilities year-on-year change?
What is Entero Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ENTO is $146.90 K
What is the all time high annual total long term liabilities for Entero Therapeutics?
Entero Therapeutics all-time high annual total long term liabilities is $7.31 M
What is Entero Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ENTO annual total long term liabilities has changed by -$67.20 K (-31.39%)
What is Entero Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ENTO is $80.20 K
What is the all time high quarterly long term liabilities for Entero Therapeutics?
Entero Therapeutics all-time high quarterly total long term liabilities is $7.31 M
What is Entero Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ENTO quarterly total long term liabilities has changed by -$66.70 K (-45.41%)